Interestingly some studies reported, as previously observed for colorectal cancer, a specific role of different KRAS somatic mutations, suggesting that a different contribute to tumor aggressiveness and treatment sensitivity could derive from different alterations in the KRAS protein structure. This evidence concerns the gene KRAS and colorectal cancer.